Regenxbio stock falls as FDA places clinical holds on key programs
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Lam Research stock price target raised to $275 from $241 at Evercore ISI
Post Content
Goldman Sachs reiterates buy rating on Progressive stock with $230 target
Post Content
Halozyme stock price target maintained at $58 by Goldman Sachs
Post Content
IBM stock price target raised to $345 from $330 at Evercore ISI
Post Content
ServiceNow stock rating reiterated at Buy by Jefferies on solid growth
Post Content
Goldman Sachs lowers Las Vegas Sands stock price target on Macau weakness
Post Content
Samsung, SK Hynix warn of squeezed chip supplies for PCs, phones due to AI boom
Post Content
AstraZeneca to invest $15 billion in China through 2030
Post Content
STMicroelectronics Q4 2025 slides: Revenue growth returns despite EPS miss
Post Content